Oxidative Stress in Motor Neuron Disease: COSMOS Add-On Study

计划入组 10 人 · 首次发布于 2010 年 6 月 14 日

Autologous Bone Marrow-Derived Stem Cell Therapy for Motor Neuron Disease

计划入组 40 人 · 首次发布于 2017 年 3 月 1 日

Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease

计划入组 20 人 · 首次发布于 2006 年 5 月 11 日

Motorgraft

ataxin2 modulator (motor neurone disease)

Allogenic spinal motor neuron precursor cell (XellSmart)

Teeter Motor Company

United States

TOYOTA MOTOR CORPORATION

Japan

Honda Motor Co Ltd

Tofersen Shows Promise in Slowing Progression of SOD1 Motor Neuron Disease

Human 3D Organoid Models Advance Mechanistic Understanding of Motor Neuron Diseases

Klotho Neurosciences Secures Australian Patent for Novel Gene Therapy Targeting Motor Neuron Diseases